Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.
Thread quality is excellent — keep it up. 👍
Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.
Thread quality is excellent — keep it up. 👍
Slightly tangential to FLOW trial semaglutide but julia.endo reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
james_edin said:Follow-up question: what labs did your doctor order to monitor this
This is exactly right. james_edin articulated what I have been trying to explain to my friends for months. The FLOW trial semaglutide aspect is what made the difference for me.
Saving this for reference. Quality thread.
Adding my data to this FLOW trial semaglutide discussion:
| Metric | Baseline | Month 3 | Month 6 |
|---|---|---|---|
| Weight | 244 lbs | 229 lbs | 219 lbs |
| A1C | 6.8% | 5.8% | 5.2% |
| hsCRP | 8.0 | 2.0 | 1.0 |
Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.6g/kg/day.